Refractory Aggressive T-Cell Non-Hodgkin Lymphoma
general50
Centers
59
Active Trials
$13.2B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Refractory B Lymphoblastic Lymphoma | 50 |
Top Centers for Refractory Aggressive T-Cell Non-Hodgkin Lymphoma(50)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →